TG Therapeutics's total assets for Q2 2025 were $702.61M, an increase of 6.99% from the previous quarter. TGTX total liabilities were $426.18M for the fiscal quarter, a 1.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.